This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Referral criteria from primary care - suspected rheumatoid arthritis (RA)

Authoring team

Refer for specialist opinion any adult with suspected persistent synovitis of undetermined cause.

Refer urgently (even with a normal acute-phase response, negative anti-cyclic citrullinated peptide [CCP] antibodies or rheumatoid factor) if any of the following apply:

  • the small joints of the hands or feet are affected
  • more than one joint is affected
  • there has been a delay of 3 months or longer between onset of symptoms and seeking medical adviceNotes:
  • suggested nvestigations
    • rheumatoid factor in people with suspected RA who are found to have synovitis on clinical examination
    • consider measuring anti-cyclic citrullinated peptide (CCP) antibodies in people with suspected RA if:
      • they are negative for rheumatoid factor, and
      • there is a need to inform decision-making about starting combination therapy
    • x-ray the hands and feet early in the course of the disease in people with persistent synovitis in these joints

Reference:

  1. NICE (July 2018). Rheumatoid arthritis- The management of rheumatoid arthritis in adults

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.